Current company-specific hook: its quarterly report sharpened attention on oncology pipeline execution. The central reader questions concern clinical evidence and regulatory planning and commercial ...

Altimmune (NASDAQ:ALT) is in focus after fresh company news highlighted trial execution and clinical differentiation, cash runway and competitive intensity, and the operating questions that matter now ...

Apple will drop support for Intel processors with the release of macOS 27 Golden Gate in the fall. Don't wait until then to upgrade.

Soaring AI infrastructure costs and model pricing, combined with uncertain returns on investment, threaten to stall enterprise adoption. To make enterprise AI spend a bit more manageable, Nvidia this ...

We have partnered on a number of projects exploring the discoverability and navigation of research by machines and humans alike, laying the groundwork for a new era of AI-driven research communication ...

The AI lab publishes a leaderboard, declares that its new model is the best, and includes a collection of graphs showing improvements ...

Because the weights are open, that entire experimentation phase can happen on a company's own hardware, with no ...

The more that men can credibly signal they will be dependable ‘dads’ and not disappointing ‘duds,’ the higher the birth rate ...

Aloi has raised $7m in early funding to develop what it calls ‘organisational judgment’, in order to improve legal AI ...

The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today announced that its Singapore investee Nanyang Biologics Pte. Ltd. ("NYB") obtained the notice of ...

Your CDN may be blocking CCBot without telling you, keeping your pages out of the archive that trains most models.